강현미 (한국생명공학연구원)님 | 한빛사연구자 > 한빛사

한국생명공학연구원

최종업데이트 2025.09.10.

Personalized pharmacokinetic-pharmacodynamic guided therapy via an induced pluripotent stem cell-derived multi-organoid platform in NF1-mutant breast cancer
- Signal Transduct. Target. Ther., Mar 05 2026, 11 (1) 79 | https://doi.org/10.1038/s41392-026-02595-7
- 2026-03
- 한빛사논문
Induction of Nephron-Ductal Dual Lineages via Early Retinoic Acid Signaling Establishes a Platform for Fully Patterned Kidney Organoids
- Adv. Healthc. Mater., Sep 04 2025, | https://doi.org/10.1002/adhm.202502044
- 2025-09
- 생명과학
- 한빛사논문
ARL6IP1 gene delivery reduces neuroinflammation and neurodegenerative pathology in hereditary spastic paraplegia model
- J. Exp. Med., November 07 2023 | https://doi.org/10.1084/jem.20230367
- 2023-11
- 의약학
- 한빛사논문
- 강현미(University of Pennsylvania)
Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development
- Nat. Med., January 2015, 21, 37-46, doi:10.1038/nm.3762
- 2015-01
- 한빛사논문, 상위피인용논문

연구자 ID

저자논문